A nurse is preparing to administer enoxaparin 5 mg/kg subcutaneous daily to a client who has deep-vein thrombosis. The client weighs 152 lb. Available is 120 mg/0.8 mL prefilled syringe. Calculate the dosage in mL that the nurse should administer. (Round the answer to the nearest tenth. Use a leading zero if applicable. Do not use a trailing zero.)
The Correct Answer is ["2.3"]
1 lb = 0.453592 kg (conversion factor)
Weight in kilograms = 152 lb × 0.453592 kg/lb ≈ 68.946 kg
Calculate the total dosage based on the client's weight:
Total dosage = 5 mg/kg × 68.946 kg
≈ 344.73mg
Determine the volume of enoxaparin solution needed based on the concentration provided: Available concentration: 120 mg/0.8 mL
Dosage required: 344.73 mg Using the formula:
Volume (mL) = Dosage required (mg) / Concentration (mg/mL)
= 344.73mg / 120 mg/0.8 mL
= 2.3ml
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
A. Slurred speech can be a symptom of lithium toxicity. As lithium levels rise in the blood, it can affect neurological function, leading to symptoms such as confusion, drowsiness, tremors, and slurred speech.
B. Stooped posture is not typically associated with lithium toxicity. It is more commonly associated with musculoskeletal issues or neurological disorders rather than lithium toxicity.
C. Elevated blood pressure is not a typical symptom of lithium toxicity. Lithium can actually have a protective effect on blood pressure, and hypertension is not commonly associated with lithium toxicity.
D. Dry cough is not a symptom of lithium toxicity. It is more commonly associated with respiratory conditions or medication side effects rather than lithium toxicity.
Correct Answer is A
Explanation
A. Hydrochlorothiazide can cause electrolyte imbalances, particularly hypokalemia (low potassium levels), hyponatremia (low sodium levels), and hypomagnesemia (low magnesium levels). Monitoring serum electrolyte levels, including potassium, sodium, and magnesium, is essential to detect and manage any abnormalities that may occur as a result of hydrochlorothiazide therapy.
B. Thyroid levels are not typically affected by hydrochlorothiazide therapy. Therefore, monitoring thyroid levels is not necessary in clients taking hydrochlorothiazide for hypertension.
C. Hydrochlorothiazide is not known to affect coagulation studies such as prothrombin time (PT), activated partial thromboplastin time (aPTT), or international normalized ratio (INR).
D. Hydrochlorothiazide is not typically associated with significant hematologic effects that would necessitate routine monitoring of the complete blood count. Therefore, monitoring CBC is not routinely indicated for clients taking hydrochlorothiazide for hypertension.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.